U.S. Physical Therapy, Inc. $USPH Shares Sold by Invesco Ltd.

Key Points

• Invesco Ltd. reduced its stake in U.S. Physical Therapy, Inc. by 28.7%, owning approximately 0.35% of the company after selling 21,609 shares in the first quarter.
• U.S. Physical Therapy reported $0.81 EPS for the last quarter, surpassing analysts' expectations of $0.71, with revenue rising 18.0% year-over-year.
• The company declared a quarterly dividend of $0.45 per share, to be paid on September 12th, resulting in an annualized yield of 2.2%.

Invesco Ltd. cut its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 28.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 53,706 shares of the company's stock after selling 21,609 shares during the period. Invesco Ltd. owned 0.35% of U.S. Physical Therapy worth $3,886,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. True North Advisors LLC boosted its holdings in U.S. Physical Therapy by 13.1% during the first quarter. True North Advisors LLC now owns 9,901 shares of the company's stock worth $716,000 after buying an additional 1,145 shares in the last quarter. Benjamin Edwards Inc. lifted its holdings in U.S. Physical Therapy by 8.4% during the first quarter. Benjamin Edwards Inc. now owns 5,958 shares of the company's stock valued at $431,000 after purchasing an additional 462 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after purchasing an additional 400 shares in the last quarter. CenterBook Partners LP purchased a new position in U.S. Physical Therapy during the first quarter valued at $1,177,000. Finally, Commerce Bank lifted its holdings in U.S. Physical Therapy by 15.4% during the first quarter. Commerce Bank now owns 3,814 shares of the company's stock valued at $276,000 after purchasing an additional 509 shares in the last quarter.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director directly owned 2,594 shares in the company, valued at $202,357.94. This trade represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Carey P. Hendrickson sold 698 shares of U.S. Physical Therapy stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $86.11, for a total transaction of $60,104.78. Following the sale, the chief financial officer owned 27,808 shares of the company's stock, valued at approximately $2,394,546.88. This represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 3,653 shares of company stock worth $311,274. Insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an "outperform" rating in a report on Friday, August 8th. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, U.S. Physical Therapy presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH traded up $1.17 during mid-day trading on Tuesday, reaching $84.06. The company's stock had a trading volume of 34,921 shares, compared to its average volume of 142,899. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The stock has a market capitalization of $1.28 billion, a P/E ratio of 36.58, a P/E/G ratio of 4.15 and a beta of 1.47. The stock has a 50-day moving average of $79.33 and a two-hundred day moving average of $76.63. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $197.34 million during the quarter, compared to analysts' expectations of $190.24 million. During the same period last year, the business earned $0.73 earnings per share. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. On average, equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.